State of Wisconsin Investment Board’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.9M | Sell |
117,296
-4,123
| -3% | -$98.2K | 0.01% | 1236 |
|
|
2025
Q4 | $2.83M | Buy |
121,419
+49,391
| +69% | +$1.1M | 0.01% | 1260 |
|
|
2025
Q3 | $1.42M | Sell |
72,028
-25,443
| -26% | -$523K | ﹤0.01% | 1484 |
|
|
2025
Q2 | $2.12M | Sell |
97,471
-35,135
| -26% | -$829K | 0.01% | 1277 |
|
|
2025
Q1 | $3.22M | Sell |
132,606
-49,171
| -27% | -$1.11M | 0.01% | 1079 |
|
|
2024
Q4 | $3.79M | Sell |
181,777
-21,693
| -11% | -$466K | 0.01% | 1058 |
|
|
2024
Q3 | $4.04M | Sell |
203,470
-32,493
| -14% | -$602K | 0.01% | 1031 |
|
|
2024
Q2 | $3.66M | Buy |
235,963
+25,561
| +12% | +$398K | 0.01% | 1059 |
|
|
2024
Q1 | $3.35M | Buy |
210,402
+57,371
| +37% | +$865K | 0.01% | 1100 |
|
|
2023
Q4 | $2.57M | Buy |
153,031
+68,203
| +80% | +$932K | 0.01% | 1177 |
|
|
2023
Q3 | $992K | Sell |
84,828
-1,846
| -2% | -$24.7K | ﹤0.01% | 1397 |
|
|
2023
Q2 | $1.16M | Sell |
86,674
-4,527
| -5% | -$65.1K | ﹤0.01% | 1417 |
|
|
2023
Q1 | $1.51M | Sell |
91,201
-6,779
| -7% | -$112K | ﹤0.01% | 1370 |
|
|
2022
Q4 | $1.82M | Sell |
97,980
-1,520
| -2% | -$23.4K | 0.01% | 1340 |
|
|
2022
Q3 | $1.28M | Sell |
99,500
-5,430
| -5% | -$64.4K | ﹤0.01% | 1453 |
|
|
2022
Q2 | $736K | Sell |
104,930
-27,470
| -21% | -$201K | ﹤0.01% | 1844 |
|
|
2022
Q1 | $1.1M | Sell |
132,400
-39,300
| -23% | -$278K | ﹤0.01% | 1623 |
|
|
2021
Q4 | $1.16M | Buy |
171,700
+39,300
| +30% | +$258K | ﹤0.01% | 1404 |
|
|
2021
Q3 | $702K | Hold |
132,400
| – | – | ﹤0.01% | 1572 |
|
|
2021
Q2 | $761K | Hold |
132,400
| – | – | ﹤0.01% | 1545 |
|
|
2021
Q1 | $610K | Hold |
132,400
| – | – | ﹤0.01% | 1523 |
|
|
2020
Q4 | $442K | Sell |
132,400
-16,500
| -11% | -$55.4K | ﹤0.01% | 1571 |
|
|
2020
Q3 | $442K | Hold |
148,900
| – | – | ﹤0.01% | 1526 |
|
|
2020
Q2 | $688K | Hold |
148,900
| – | – | ﹤0.01% | 1330 |
|
|
2020
Q1 | $573K | Buy |
148,900
+4,200
| +3% | +$17.2K | ﹤0.01% | 1319 |
|
|
2019
Q4 | $543K | Hold |
144,700
| – | – | ﹤0.01% | 1413 |
|
|
2019
Q3 | $768K | Buy |
144,700
+13,500
| +10% | +$71.9K | ﹤0.01% | 1196 |
|
|
2019
Q2 | $504K | Buy |
131,200
+2,900
| +2% | +$12.5K | ﹤0.01% | 1322 |
|
|
2019
Q1 | $654K | Buy |
128,300
+29,300
| +30% | +$86.1K | ﹤0.01% | 1274 |
|
|
2018
Q4 | $190K | Buy |
99,000
+45,000
| +83% | +$129K | ﹤0.01% | 1458 |
|
|
2018
Q3 | $204K | Hold |
54,000
| – | – | ﹤0.01% | 1499 |
|
|
2018
Q2 | $168K | Hold |
54,000
| – | – | ﹤0.01% | 1433 |
|
|
2018
Q1 | $129K | Hold |
54,000
| – | – | ﹤0.01% | 1420 |
|
|
2017
Q4 | $211K | Hold |
54,000
| – | – | ﹤0.01% | 1385 |
|
|
2017
Q3 | $136K | Hold |
54,000
| – | – | ﹤0.01% | 1425 |
|
|
2017
Q2 | $149K | Buy |
+54,000
| New | +$113K | ﹤0.01% | 1421 |
|
Other funds holding CPRX
VCM
DM
VPM
State of Wisconsin Investment Board's CPRX Position: Q1 2026 in Review
State of Wisconsin Investment Board reduced its Catalyst Pharmaceutical (CPRX) stake by 3.4% in Q1 2026, selling an estimated $98.2K and leaving 117,296 shares worth $2.9M. The position accounts for 0.01% of the portfolio, ranked #1236.
State of Wisconsin Investment Board first reported a position in CPRX in Q2 2017 and has held it in 36 quarters since. The position peaked at $4.04M in Q3 2024. 381 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- State of Wisconsin Investment Board held 117,296 shares of Catalyst Pharmaceutical worth $2.9M as of Q1 2026.
- State of Wisconsin Investment Board sold 4,123 Catalyst Pharmaceutical shares in Q1 2026, an estimated $98.2K.
- Catalyst Pharmaceutical made up 0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1236 holding.
- State of Wisconsin Investment Board first reported a position in Catalyst Pharmaceutical in Q2 2017 and has held it in 36 quarters since.
- State of Wisconsin Investment Board's Catalyst Pharmaceutical position peaked at $4.04M in Q3 2024.
- 381 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.